4 | SEC Filings Hub

Filing metadata

Accession number: 0001062993-22-023361
Form type: Form 4
Filer: ENANTA PHARMACEUTICALS INC
CIK: CIK 1177648
Filed: Dec 05, 2022
Reporting period: Dec 01, 2022
Description: Insider transaction

Documents

0001062993-22-023361-index.htm

Complete submission

0001062993-22-023361.txt

directory listing

Filed by

ENANTA PHARMACEUTICALS INC